Stay updated on Inhaled GB002 for PAH: Phase III Clinical Trial

Sign up to get notified when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled GB002 for PAH: Phase III Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T21:52:14.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T22:00:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.6 to v3.7.0, marking a new version in the study record's history.
    Difference
    0.1%
    Check dated 2026-09-19T21:47:13.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' was added to the version history, and the previous 'Revision: v3.6.5' entry was removed. This updates the page's historical revision information to reflect the latest change to the study record display.
    Difference
    0.1%
    Check dated 2026-08-29T18:31:52.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page history now lists Revision: v3.6.5 in place of v3.6.4, signaling a platform version update to the record history interface.
    Difference
    0.1%
    Check dated 2026-08-08T10:26:44.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The sponsor subsidiary name is updated from Gossamer Bio Inc. to Gossamer Bio USA, Inc., and the revision/version is updated from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-25T06:39:30.000Z thumbnail image

Stay in the know with updates to Inhaled GB002 for PAH: Phase III Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.